000520.KS
Samil Pharmaceutical Co.,Ltd
KSC · Healthcare · Drug Manufacturers - Specialty & Generic · KR
KRW 6,080.00
−0.82%Margins
Gross margin
32.1%
EBITDA margin
-19.0%
EBIT margin
-14.5%
Net margin
-18.1%
FCF margin
-3.6%
-29.9%
Return on equity
-10.0%
Return on assets
-10.0%
Return on invested capital
0.56x
Asset turnover
-KRW 26.1M
Cash from operations
KRW 288
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026